Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD166 Antikörper (AA 405-524)

ALCAM Reaktivität: Human IHC, ELISA Wirt: Maus Monoclonal 10F1G12 unconjugated
Produktnummer ABIN968954
  • Target Alle CD166 (ALCAM) Antikörper anzeigen
    CD166 (ALCAM) (Activated Leukocyte Cell Adhesion Molecule (ALCAM))
    Bindungsspezifität
    • 16
    • 13
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 405-524
    Reaktivität
    • 92
    • 28
    • 22
    • 17
    • 2
    • 1
    Human
    Wirt
    • 63
    • 39
    • 3
    • 1
    • 1
    Maus
    Klonalität
    • 65
    • 42
    Monoklonal
    Konjugat
    • 49
    • 15
    • 11
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CD166 Antikörper ist unkonjugiert
    Applikation
    • 66
    • 43
    • 36
    • 27
    • 13
    • 13
    • 12
    • 8
    • 7
    • 6
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), ELISA
    Verwendungszweck
    ALCAM Antibody
    Aufreinigung
    Ascitic fluid
    Immunogen
    Purified recombinant fragment of ALCAM (aa405-524) expressed in E. Coli.
    Klon
    10F1G12
    Isotyp
    IgG1
    Top Product
    Discover our top product ALCAM Primärantikörper
  • Applikationshinweise
    ELISA: 1/10000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Jezierska, Matysiak, Motyl: "ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy." in: Medical science monitor : international medical journal of experimental and clinical research, Vol. 12, Issue 8, pp. BR263-73, (2006) (PubMed).

    Zimmerman, Nelissen, van Emst-de Vries, Willems, de Lange, Collard, van Leeuwen, Figdor: "Cytoskeletal restraints regulate homotypic ALCAM-mediated adhesion through PKCalpha independently of Rho-like GTPases." in: Journal of cell science, Vol. 117, Issue Pt 13, pp. 2841-52, (2004) (PubMed).

    Fujiwara, Tatsumi, Kosaka, Sato, Higuchi, Yoshioka, Maeda, Ueda, Fujii: "Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166)." in: The Journal of clinical endocrinology and metabolism, Vol. 88, Issue 7, pp. 3437-43, (2003) (PubMed).

    Zutt, Emmert, Hänssle, Gräfe, Domhof, Neumann, Kretschmer: "[Improved scar formation after using a medical surgical zipper for wound closure under tension]." in: Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete, Vol. 54, Issue 4, pp. 342-7, (2003) (PubMed).

  • Target
    CD166 (ALCAM) (Activated Leukocyte Cell Adhesion Molecule (ALCAM))
    Andere Bezeichnung
    ALCAM (ALCAM Produkte)
    Hintergrund

    Description: ALCAM(CD166): Activated leukocyte cell adhesion molecule.CD166 is a member of the Ig superfamily and is expressed on activated T-cells, B cells and other cells including thymic epithelial cells, fibroblasts, keratinocytes and neurons. CD6 has been identified as a receptor for CD166.

    Aliases: MEMD, CD166, ALCAM

    Gen-ID
    214
    HGNC
    214
    UniProt
    Q13740
Sie sind hier:
Kundenservice